Movement Alert｜Twist Bioscience Corp Falls 6.22% in Pre-Market Trading, Fiscal Q3 Loss Wider Than Expected Despite Revenue Beat

Market Focus08-03

On August 3, Twist Bioscience Corp declined 6.22% in pre-market trading, trading at approximately $87.26/share, with turnover of $55,200. The decline was triggered by the company's fiscal third-quarter earnings report showing a wider-than-expected net loss.

Twist Bioscience posted a fiscal Q3 net loss of $0.56 per diluted share, swinging sharply from earnings of $0.33 a year earlier and missing the analyst consensus estimate of a $0.51 loss. Revenue for the quarter ended June 30 came in at $118.4 million, up 23.2% year-over-year and above the $114.5 million analyst estimate. The company raised its full-year fiscal 2026 revenue outlook to $456 million to $457 million from a prior range of $442 million to $447 million, exceeding the Street estimate of $446.4 million. Fiscal Q4 revenue guidance of $123 million to $124 million also topped the $117.4 million consensus.

Despite the revenue beat and raised guidance, investors appear focused on the magnitude of the earnings miss and the swing from profitability to a loss, pressuring shares in early trading.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1172058085?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-03 19:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1172058085","market":"us","top_or_hot":-1,"title":"Movement Alert｜Twist Bioscience Corp Falls 6.22% in Pre-Market Trading, Fiscal Q3 Loss Wider Than Expected Despite Revenue Beat","media":"Market Focus","content":"<p><p>On August 3, Twist Bioscience Corp declined 6.22% in pre-market trading, trading at approximately $87.26/share, with turnover of $55,200. The decline was triggered by the company's fiscal third-quarter earnings report showing a wider-than-expected net loss.</p><p>Twist Bioscience posted a fiscal Q3 net loss of $0.56 per diluted share, swinging sharply from earnings of $0.33 a year earlier and missing the analyst consensus estimate of a $0.51 loss. Revenue for the quarter ended June 30 came in at $118.4 million, up 23.2% year-over-year and above the $114.5 million analyst estimate. The company raised its full-year fiscal 2026 revenue outlook to $456 million to $457 million from a prior range of $442 million to $447 million, exceeding the Street estimate of $446.4 million. Fiscal Q4 revenue guidance of $123 million to $124 million also topped the $117.4 million consensus.</p><p>Despite the revenue beat and raised guidance, investors appear focused on the magnitude of the earnings miss and the swing from profitability to a loss, pressuring shares in early trading.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Twist Bioscience Corp Falls 6.22% in Pre-Market Trading, Fiscal Q3 Loss Wider Than Expected Despite Revenue Beat</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Twist Bioscience Corp Falls 6.22% in Pre-Market Trading, Fiscal Q3 Loss Wider Than Expected Despite Revenue Beat\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-03 19:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 3, Twist Bioscience Corp declined 6.22% in pre-market trading, trading at approximately $87.26/share, with turnover of $55,200. The decline was triggered by the company's fiscal third-quarter earnings report showing a wider-than-expected net loss.</p><p>Twist Bioscience posted a fiscal Q3 net loss of $0.56 per diluted share, swinging sharply from earnings of $0.33 a year earlier and missing the analyst consensus estimate of a $0.51 loss. Revenue for the quarter ended June 30 came in at $118.4 million, up 23.2% year-over-year and above the $114.5 million analyst estimate. The company raised its full-year fiscal 2026 revenue outlook to $456 million to $457 million from a prior range of $442 million to $447 million, exceeding the Street estimate of $446.4 million. Fiscal Q4 revenue guidance of $123 million to $124 million also topped the $117.4 million consensus.</p><p>Despite the revenue beat and raised guidance, investors appear focused on the magnitude of the earnings miss and the swing from profitability to a loss, pressuring shares in early trading.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TWST","symbol_name":"Twist Bioscience Corp","start_time":0,"source_url":"","article_id":"1172058085","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1172058085","pubTimestamp":1785757063,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 3, Twist Bioscience Corp declined 6.22% in pre-market trading, trading at approximately $87.26/share, with turnover of $55,200. The decline was triggered by the company's fiscal...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TWST":"Twist Bioscience Corp"},"translate_title":"走势警报|Twist Bioscience Corp 在盘前交易中下跌 6.22%，尽管收入超出预期，但第三财季亏损幅度超出预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TWST":1},"content_text":"On August 3, Twist Bioscience Corp declined 6.22% in pre-market trading, trading at approximately $87.26/share, with turnover of $55,200. The decline was triggered by the company's fiscal third-quarter earnings report showing a wider-than-expected net loss.Twist Bioscience posted a fiscal Q3 net loss of $0.56 per diluted share, swinging sharply from earnings of $0.33 a year earlier and missing the analyst consensus estimate of a $0.51 loss. Revenue for the quarter ended June 30 came in at $118.4 million, up 23.2% year-over-year and above the $114.5 million analyst estimate. The company raised its full-year fiscal 2026 revenue outlook to $456 million to $457 million from a prior range of $442 million to $447 million, exceeding the Street estimate of $446.4 million. Fiscal Q4 revenue guidance of $123 million to $124 million also topped the $117.4 million consensus.Despite the revenue beat and raised guidance, investors appear focused on the magnitude of the earnings miss and the swing from profitability to a loss, pressuring shares in early trading.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"dataReport,movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1172058085","isCrawlerRequest":true}